Exclusive

Publication

Byline

Location

US Patent Issued to BPGbio on July 28 for "Methods for the treatment of cancer using coenzyme Q10 combination therapies" (Massachusetts Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,081, issued on July 28, was assigned to BPGbio Inc. (Waltham, Mass.). "Methods for the treatment of cancer using coenzyme Q10 combination t... Read More


US Patent Issued to Vitalis Analgesics on July 28 for "Oral administration of ketamine" (New York Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,082, issued on July 28, was assigned to Vitalis Analgesics LLC (Wilmington, Del.). "Oral administration of ketamine" was invented by Joseph... Read More


US Patent Issued to DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION on July 28 for "Pharmaceutical composition for preventing or treating attention deficit/hyperactivity disorder, containing KDS2010 as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,083, issued on July 28, was assigned to DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION (Cheonan-si, South Korea)... Read More


US Patent Issued to INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY on July 28 for "Pharmaceutical composition for preventing or treating bone diseases" (South Korean Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,084, issued on July 28, was assigned to INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (Gwangju, South Korea). "Pharmaceutical composit... Read More


US Patent Issued to OSARTIS on July 28 for "Cancer treatment composition and method" (Florida Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,085, issued on July 28, was assigned to OSARTIS GmbH (Muenster, Germany). "Cancer treatment composition and method" was invented by Matthew... Read More


US Patent Issued to HORIZON THERAPEUTICS IRELAND DAC on July 28 for "Methods of treating systemic sclerosis and idiopathic pulmonary fibrosis" (Irish Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,086, issued on July 28, was assigned to HORIZON THERAPEUTICS IRELAND DAC (Dublin). "Methods of treating systemic sclerosis and idiopathic p... Read More


US Patent Issued to THE INSTITUTE FOR ETHNOMEDICINE on July 28 for "Method of enhancing glucose levels in the central nervous system" (Wyoming Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,087, issued on July 28, was assigned to THE INSTITUTE FOR ETHNOMEDICINE (Jackson, Wyo.). "Method of enhancing glucose levels in the central... Read More


US Patent Issued to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK on July 28 for "Reactivation of mTOR in acute kidney injury (AKI)" (New York Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,088, issued on July 28, was assigned to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York). "Reactivation of mTOR in ac... Read More


US Patent Issued to Xeris Pharmaceuticals on July 28 for "Stable levothyroxine compositions in aprotic polar solvents" (California, Illinois, Texas Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,089, issued on July 28, was assigned to Xeris Pharmaceuticals Inc. (Chicago). "Stable levothyroxine compositions in aprotic polar solvents"... Read More


US Patent Issued to XWPharma on July 28 for "Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative" (California, Minnesota Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,090, issued on July 28, was assigned to XWPharma Ltd. (Grand Cayman, Cayman Islands). "Pharmacokinetics of combined release formulations of... Read More